https://www.medpagetoday.com/meetingcoverage/esc/100432
0
0
8/27/22 at 8:03pm
Organization
MedPage Today
Author
Ed Susman
26 words
0
Comments
Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says
You are the first to view
Create an account
or login to join the discussion